Target Details
| UniProt AC | P04049 |
|---|---|
| Gene Symbol | RAF1 |
| Protein Name | RAF proto-oncogene serine/threonine-protein kinase |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00130 (C1_1) PF07714 (PK_Tyr_Ser-Thr) PF02196 (RBD) |
Summary
- Multi-target molecules 2,133
- Clinical molecules 20
- Avg pChEMBL 8.1
KEGG Pathways (84)
- Acute myeloid leukemia
- Alcoholism
- Alzheimer disease
- Apelin signaling pathway
- Apoptosis
- Autophagy - animal
- Axon guidance
- B cell receptor signaling pathway
- Bladder cancer
- Breast cancer
- C-type lectin receptor signaling pathway
- Cadherin signaling
- Cellular senescence
- Central carbon metabolism in cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Chronic myeloid leukemia
- Colorectal cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Fc gamma R-mediated phagocytosis
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH secretion
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- Influenza A
- Insulin signaling pathway
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanogenesis
- Melanoma
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Neutrophil extracellular trap formation
- Non-small cell lung cancer
- Oxytocin signaling pathway
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phospholipase D signaling pathway
- Progesterone-mediated oocyte maturation
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Renal cell carcinoma
- Salmonella infection
- Serotonergic synapse
- Signaling pathways regulating pluripotency of stem cells
- Sphingolipid signaling pathway
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Tuberculosis
- VEGF signaling pathway
- Vascular smooth muscle contraction
- cAMP signaling pathway
- cGMP-PKG signaling pathway
- mTOR signaling pathway
Associated Diseases (4)
Active Molecules (2,133)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
LGMCTZVEXBYIIM
|
9.5 | IC50 | 3 | — | |
DEFBACDLTQLHSG
|
9.5 | IC50 | 2 | — | |
HZGBRTKLYANMLH
|
9.5 | IC50 | 2 | — | |
KYDSKCOSDPLKLI
|
9.5 | IC50 | 2 | — | |
WQOBMKLNZZRYPF
|
9.5 | IC50 | 2 | — | |
XZIVZTDFRWAEMZ
|
9.5 | IC50 | 2 | — | |
URECZFRBORHDEQ
|
9.4 | IC50 | 2 | — | |
VCRWYFQGTCFZDJ
|
9.4 | IC50 | 2 | — | |
CVUARWCEZRGONB
|
9.4 | IC50 | 2 | — | |
DJEJCPKGTQTKTH
|
9.4 | IC50 | 2 | — | |
JSNUOUDTFPPBCQ
|
9.4 | IC50 | 2 | — | |
YWXHCAQISAEKBP
|
9.4 | IC50 | 2 | — | |
JPACQCNZTJFXRL
|
9.4 | IC50 | 2 | — | |
OWLWCBXQZLBGRU
|
9.4 | IC50 | 2 | — | |
PRPZEFLLWATTOC
|
9.4 | IC50 | 2 | — | |
SDIALWKFQDWRQM
|
9.4 | IC50 | 2 | — | |
YEJHEWNOBBCKFK
|
9.4 | IC50 | 2 | — | |
YFCGZSBLRQTQCQ
|
9.4 | IC50 | 2 | — | |
NRIIVZIVGFDQHT
|
9.4 | IC50 | 2 | — | |
OJMHBRGTXHCAEY
|
9.4 | IC50 | 2 | — | |
PALWFNXLARYKAG
|
9.4 | IC50 | 2 | — | |
RXHCQJSVKSFKKA
|
9.4 | IC50 | 2 | — | |
ATBFVPIZYSUOTG
|
9.4 | IC50 | 2 | — | |
BPWZHHUEZAZOGP
|
9.4 | IC50 | 2 | — | |
OULIDKUUWCWYAF
|
9.4 | IC50 | 2 | — | |
RQGAPFNBWMMRNO
|
9.4 | IC50 | 2 | — | |
AKCLRSIFAYFSML
|
9.4 | IC50 | 2 | — | |
BBYSQEOZCZKTEU
|
9.4 | IC50 | 2 | — | |
BFOACAOHDXZAEA
|
9.4 | IC50 | 2 | — | |
BFOXOBQAFQGJLK
|
9.4 | IC50 | 2 | — | |
BSUIIPUXGLKINZ
|
9.4 | IC50 | 2 | — | |
CASQHERFADFEPM
|
9.4 | IC50 | 2 | — | |
COCBCTNHHCFGCB
|
9.4 | IC50 | 2 | — | |
CPQCRZXCFJSDSG
|
9.4 | IC50 | 2 | — | |
CRNMRBXHDKNNKK
|
9.4 | IC50 | 2 | — | |
CSLYSZPPFQPIIR
|
9.4 | IC50 | 2 | — | |
CTUGLUQSZFLOBO
|
9.4 | IC50 | 2 | — | |
DBCCYBRCXIDJHP
|
9.4 | IC50 | 2 | — | |
DUSJGQQKHPLAEP
|
9.4 | IC50 | 2 | — | |
DVBQSUVLJKVUBQ
|
9.4 | IC50 | 2 | — | |
DZVUMQLQVYBRHR
|
9.4 | IC50 | 2 | — | |
FFRQDGGNVABUME
|
9.4 | IC50 | 2 | — | |
FLNNBUNPCWDUJJ
|
9.4 | IC50 | 2 | — | |
FRTRWUVXRSFSHD
|
9.4 | IC50 | 2 | — | |
FTOQSSWEKQRPCE
|
9.4 | IC50 | 2 | — | |
GCVLGXWDFGPGDP
|
9.4 | IC50 | 2 | — | |
GJBWANRWQWONGM
|
9.4 | IC50 | 2 | — | |
GQKRUHLMMBPTEC
|
9.4 | IC50 | 2 | — | |
GRNQCTMTIYRPGV
|
9.4 | IC50 | 2 | — | |
HJZOLMWTAJVUIP
|
9.4 | IC50 | 2 | — |